Biotricity announces the expansion of its cardiac diagnostics portfolio through strategic partnerships with a leading home-based neurology company and a leading home-based sleep apnea diagnostic company. Individuals suffering from sleep or neurological disorders have elevated risks for cardiac issues. These collaborations position Biotricity and its partners as comprehensive providers of holistic screenings, marking a significant advancement in Biotricity’s mission to offer integrated healthcare solutions that address the complex needs of patients with multiple conditions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTCY:
- Biotricity announces ‘high demand’ for Biotres Pro
- Biotricity launches cardiac monitoring pilot program with hospital system
- Biotricity launches cardiac monitoring pilot program with hospital network
- Biotricity enters partnership with third major group purchasing organization
- Biotricity partners with Health Aid Africa